Trillium Therapeutics Inc.
Fluorinated imidazo[4,5-C]quinoline derivatives as inhibitors of bromodomain containing proteins
Last updated:
Abstract:
A novel class of fluorinated derivatives of Formula I have been prepared and found to be useful in the treatment of cancers and other disorders related mediated by Bromodomain-Containing Proteins. ##STR00001##
Status:
Grant
Type:
Utility
Filling date:
11 Mar 2019
Issue date:
30 Jun 2020